Login
Related Links
Breaking Gene Therapy News
Breaking gene therapy news items collected via Google News. Current news results for 'gene therapy' are sorted by date. Login and view all archived news items.
- AaviGen, SK pharmteco Announce Manufacturing Agreement for Heart Failure Gene Therapy - BioPharm International
Sat, 12 Oct 2024 17:37:1 GMT - HNSA-5487 Significantly Reduces IgG Levels, FDA Removes Hold on AOC 1001, DMD Gene Therapy Shows No Impact on Cardiac Outcomes - Neurology Live
Sat, 12 Oct 2024 13:09:1 GMT - Gene therapy benefits boys with rare brain disease, but hematologic cancer remains a risk - Healio
Fri, 11 Oct 2024 17:30:2 GMT - Fierce Pharma Asia—AstraZeneca-CSPC heart med deal; Astellas' gene therapy pact, new cell therapy site - FiercePharma
Fri, 11 Oct 2024 15:48:5 GMT - Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy - Benzinga
Fri, 11 Oct 2024 15:09:1 GMT - Buy, Sell, Hold: Cell and Gene Therapy - Pharmaceutical Technology Magazine
Fri, 11 Oct 2024 13:01:3 GMT - Magnetically regulated gene therapy tech offers precise brain-circuit control - Medical Xpress
Thu, 10 Oct 2024 20:25:0 GMT - Hubble Therapeutics Taps Andelyn to Manufacture Clinical Grade AAV for Eye Disorder Gene Therapy - Genetic Engineering & Biotechnology News
Thu, 10 Oct 2024 19:29:0 GMT - Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials - Pharmaceutical Technology
Thu, 10 Oct 2024 18:24:3 GMT - Report gives update on boys with rare brain disease 6 years after gene therapy - UPI News
Thu, 10 Oct 2024 16:10:4 GMT - Sarepta’s gene therapy is fully approved, but its stock has tanked. Here’s why - STAT
Thu, 10 Oct 2024 16:02:5 GMT - Magnetically Regulated Gene Therapy Tech Offers Precise Brain-Circuit Control - Weill Cornell Medicine Newsroom
Thu, 10 Oct 2024 15:33:5 GMT - 7 Children Receiving Bluebird’s Gene Therapy Developed Blood Cancers: Study - BioSpace
Thu, 10 Oct 2024 15:18:5 GMT - Highly targeted approach supports ALS gene therapy development - ALS News Today
Thu, 10 Oct 2024 15:14:0 GMT - Advancing gene therapy for kidney disease, Purespring adds £80M - BioWorld Online
Thu, 10 Oct 2024 15:00:0 GMT - Pediatric Hearing Loss: CMV Detection, Cochlear Implants and Gene Therapy - MedicalExpo e-Magazine
Thu, 10 Oct 2024 11:03:0 GMT - Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk - Medpage Today
Wed, 09 Oct 2024 23:44:3 GMT - Gene therapy dilemma: Treatment that halts brain disease can also cause cancer - Science
Wed, 09 Oct 2024 23:15:0 GMT - 7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease - STAT
Wed, 09 Oct 2024 23:03:0 GMT - Gene therapy shows long-term benefit for patients with a rare pediatric brain disease - Medical Xpress
Wed, 09 Oct 2024 23:00:0 GMT - Gene Therapy Researcher's Patent Dispute Cleared to Proceed Against UPenn, Program Director - Law.com
Wed, 09 Oct 2024 22:26:0 GMT - Around the Helix: Cell and Gene Therapy Company Updates – October 9, 2024 - CGTLive™
Wed, 09 Oct 2024 21:39:1 GMT - Novel gene therapy shows promise in targeting a mutation linked to epilepsy - Medical Xpress
Wed, 09 Oct 2024 21:07:0 GMT - Purespring raises $105M to advance gene therapy for kidney disease - BioPharma Dive
Wed, 09 Oct 2024 18:11:2 GMT - Purespring secures $105m to start Phase I/II trial of IgAN gene therapy - Clinical Trials Arena
Wed, 09 Oct 2024 16:51:2 GMT - Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector - BioSpace
Wed, 09 Oct 2024 16:17:1 GMT - InspiroGene by McKesson Unveils First-of-its-Kind Report on State of the Cell and Gene Therapy Landscape, Revealing Unparalleled Optimism Amidst Complex Challenges - Business Wire
Wed, 09 Oct 2024 13:00:0 GMT - AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial - Nature.com
Wed, 09 Oct 2024 11:50:5 GMT - Still Looking For A Gene Therapy Hit, Syncona Backs Purespring In IgA Nephropathy Market - scrip.citeline.com
Wed, 09 Oct 2024 09:00:0 GMT - Purespring bottles up $105M series B to bring kidney disease gene therapy to the clinic - Fierce Biotech
Wed, 09 Oct 2024 08:00:0 GMT
Special News Items
- Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
- ISCT Becomes the First Cell and Gene Therapy Organization to Achieve ANAB Accreditation for Workforce Development
- First patient dosed in uniQure trial of AMT-191 gene therapy for Fabry
- Researchers say gene therapy breakthrough shows promise for glaucoma
- Switching Gene Therapy On and Off with a Pill
- Toddler Born Deaf Can Hear After Gene Therapy Trial Breakthrough Her Parents Call "Mind-Blowing"
- First Patient Begins Newly Approved Sickle Cell Gene Therapy
- FDA approves Orchard’s Lenmeldy gene therapy for MLD
- Team performs the first gene therapy tests in a whole human liver
- Gene Therapy Success in Hereditary Angioedema Patients
- FDA Approves CRISPR Gene Therapy to Treat Blood Disorder
- FDA Signals Imminent Approval for Sarepta’s Duchenne Gene Therapy: A Major Breakthrough for Patients
- Revolutionary gene therapy shows promise in treating autism
- Cell & Gene Therapy Space Gears Up for First CRISPR Approval
- Gene therapy restores hearing in children with rare form of deafness
- UK biotech AlveoGene launches with plans for inhaled gene therapy
- Gene Therapy Targets Chronic Pain
- Gene therapy eyedrops restored a boy's sight. Similar treatments could help millions
- Gene therapy approved by FDA for certain boys with rare genetic condition
- FDA Needs More Cell, Gene Therapy Mid Managers to Speed Reviews
- Biology Professor Venigalla Rao Makes Breakthrough on Gene Therapy Research
- Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS)
- Bacterial ‘Nanosyringe’ Could Deliver Gene Therapy to Human Cells
- EU approves Hemgenix, one-time gene therapy for hemophilia B
- FDA officials offer advice on gene therapy trials
- New gene therapy delivers treatment directly to brain
- FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
- FDA Approves First Gene Therapy for Hemophilia B
- FDA finalizes neurodegenerative disease gene therapy guidance
- Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness